Risankizumab On-body Injector (OBI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Risankizumab On-body Injector (OBI), covering 2025-06-29 to 2025-06-29. Get the full timeline:
Most recent: Clinical Trial Update: An Observational Study to Assess Participant-Reported Real-World Experience of Risankizumab On-body Injector (OBI) for the Treatment of Crohn's Disease in Adult Participants in the United Kingdom (UK)